Examining fair lung cancer screening strategies for better health outcomes.
Equity Implications of Lung Cancer Screening Strategies for Population Health: a Distributional Cost-Effectiveness Analysis
This study is looking at how different ways to screen for lung cancer can help improve health for everyone, especially for Black and low-income people, by figuring out the best methods to find those at higher risk and making sure everyone gets fair access to these screenings.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project ID | NIH-11039111 on NIH RePORTER |
What this research studies
This research investigates how different lung cancer screening strategies can impact health outcomes, particularly for populations facing health disparities, such as Black and low-income Americans. It evaluates the effectiveness of low-dose computed tomography (LDCT) screening and explores whether using risk prediction models can improve the identification of individuals at high risk for lung cancer. By analyzing cost-effectiveness and health benefits, the study aims to ensure that screening guidelines are equitable and beneficial for all eligible individuals. The research will utilize updated guidelines from the U.S. Preventive Services Task Force and the American Cancer Society to assess the distribution of health benefits across different populations.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals aged 50 to 80 years with a significant smoking history, particularly those from Black or low-income backgrounds.
Not a fit: Patients who have never smoked or are outside the age range of 50 to 80 years may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more equitable lung cancer screening practices that significantly reduce mortality rates in underserved populations.
How similar studies have performed: Previous studies have shown that both USPSTF guidelines and risk prediction models can be cost-effective, indicating potential for success in this area of research.
Where this research is happening
Winston-Salem, United States
- Wake Forest University Health Sciences — Winston-Salem, United States (Active)
Researchers
- Principal investigator: Lin, Meng-Yun — Wake Forest University Health Sciences
- Study coordinator: Lin, Meng-Yun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.